Enter a Ticker Symbol To Get Your Free Bull/Bear Rating & Ranking Report from "Stock Scientist" Mike Turner

Dividend Quote

BIEI

Premier Biomedical Inc

Add to Scorecard

New Report from the Award-winning Analyst Who Beat the Market Over 15 Years

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.

BIEI:Premier Biomedical Inc - Stock Quote and Dividend Data

LATEST CLOSE PRICE

$0.09

EXCHANGE

OTCBB

SECTOR

Health Care

BIEI
Premier Biomedical Inc Dividend Information
Trailing 12 Month Dividend Yield0.00%
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years

Dividend Payment TypeNone
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone

FREE INVESTOR BRIEFING

Collect an 8% Yield on this "Government Mandated Income Opportunity"

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.
BIEI
Premier Biomedical Inc Stock Information
Latest Close Price$0.09
52-Week Low/High$0.04 - $2.45
Percent Held by Institutions0.00%
Revenue$54,419
Net Income$-1,169,304
Cash Flow$-127,115
EPS-0.11%
Market Cap$457,235
PE Ratio0
PE Ratio to Industry66%
Debt-Equity Ratio999,999.00%
Debt-Equity to Industry1.38%
Total Return Last 12 Months-90.00%
Total Return Last 3 Years-98.64%
Total Return Last 5 Years-99.94%
Latest Trade DateDec. 12, 2018
BIEI
Premier Biomedical Inc Dividend Payment History

No Data available for Payment History.

BIEI
Premier Biomedical Inc Other Details

Premier Biomedical is a research-based company focusing on medical treatments for humans, targeting the treatment of: cancer, multiple sclerosis (MS), neuropathic pain, amyotrophic lateral sclerosis (ALS/Lou Gehrig's disease), fibromyalgia, traumatic brain injury (TBI), Alzheimer's disease, and blood sepsis and viremia. Co. has a three-fold corporate focus: developing and marketing cannabis-based pain management products; developing its proprietary Sequential-Dialysis Technique, targeting cancer, Alzheimer's disease, ALS, blood sepsis, leukemia, and other life-threatening cancers; and developing its drug candidate, Feldetrex™ for the treatment of MS, fibromyalgia, neuropathic pain and TBI.

Web Sitewww.premierbiomedical.com
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Try Dividend Investor PREMIUM for as low as $29

  • Dividend Allstars™ Tool
  • Proprietary Ex-dividend Calendar
  • Dividend Scorecard™ Portfolio Tracker
  • Customized Dividend Stock Screener
  • 4 FREE special reports from leading dividend experts
  • And much more...
 
Premier Biomedical Inc Dividend Stock News and Updates

Dec. 12, 2018CLOSE PRICE INCREASE: Premier Biomedical Inc (OTCBB: BIEI) on 12-12-2018 increased close price > 10% from $0.05 to $0.09

Read more...

Dec. 11, 2018CLOSE PRICE DECREASE: Premier Biomedical Inc (OTCBB: BIEI) on 12-11-2018 decreased close price > 10% from $0.07 to $0.05

Read more...

Dec. 08, 2018CLOSE PRICE DECREASE: Premier Biomedical Inc (OTCBB: BIEI) on 12-08-2018 decreased close price > 10% from $0.09 to $0.07

Read more...
More Premier Biomedical Inc Dividend News
Biotechnology Dividend Stock News and Updates

Dec. 13, 2018CLOSE PRICE DECREASE: Anthera Pharmaceuticals Inc (OTCBB: ANTH) on 12-13-2018 decreased close price > 10% from $0.05 to $0.04

Read more...

Dec. 13, 2018CLOSE PRICE DECREASE: Arno Therapeutics, Inc. (OTCBB: ARNI) on 12-13-2018 decreased close price > 10% from $0.00 to $0.00

Read more...

Dec. 13, 2018CLOSE PRICE DECREASE: Genenews Ltd (OTCBB: GNWSF) on 12-13-2018 decreased close price > 10% from $0.03 to $0.02

Read more...
More Biotechnology Dividend News
FREE REPORT
X
Bryan Perry Dividend Income Expert Bryan Perry

Earn 8% on this "Government Mandated Income Opportunity"

X

Search Dividend Investor